Compare RBB & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBB | SOPH |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.2M | 330.4M |
| IPO Year | 2017 | 2021 |
| Metric | RBB | SOPH |
|---|---|---|
| Price | $22.21 | $4.68 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $22.33 | $7.00 |
| AVG Volume (30 Days) | 57.5K | ★ 104.4K |
| Earning Date | 02-02-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $104,588,000.00 | $73,297,000.00 |
| Revenue This Year | $20.23 | $18.32 |
| Revenue Next Year | $10.98 | $15.61 |
| P/E Ratio | $14.96 | ★ N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $14.40 | $2.58 |
| 52 Week High | $23.50 | $5.30 |
| Indicator | RBB | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 73.59 | 49.47 |
| Support Level | $21.77 | $4.54 |
| Resistance Level | $21.65 | $4.84 |
| Average True Range (ATR) | 0.50 | 0.28 |
| MACD | 0.12 | -0.03 |
| Stochastic Oscillator | 88.49 | 14.47 |
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.